Newsroom

Press Releases

BioAgilytix Triangle Business Journal Fast 50 Award 2024

Press Release

BioAgilytix Honored as Triangle Business Journal Fast 50 Award Recipient for 2024 

BioAgilytix Triangle Business Journal Fast 50 Award 2024

Press Release

BioAgilytix Expands Bioanalytical Leadership with Appointment of CIO and CPO 

Durham, NC – November 4, 2024 – BioAgilytix, the leading global bioanalytical service provider, is proud to announce an expansion of its leadership team with…

Press Release

BioAgilytix Strengthens European Bioanalytical Expansion, Appoints Dr. Kay Schroeter as General Manager in Hamburg

Hamburg, Germany – October 23, 2024 – BioAgilytix, a leading global bioanalytical laboratory, is proud to announce the appointment of Dr. Kay Schroeter as the…

Press Release

BioAgilytix Unveils 360biolabs’ Expanded Cutting-Edge Laboratory in Melbourne 

Melbourne, Australia – 360biolabs, a BioAgilytix Company, proudly announces the grand opening of a state-of-the-art bioanalytical laboratory in Melbourne, Australia. 360biolabs is Australia’s most comprehensive…

Media Coverage

Media Coverage

Boosting Hamburg as a Science and Pharmaceutical Location Together With BioAgilytix

Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters…

Media Coverage

Pre-existing Immunogenicity: How Will Cell and Gene Therapies Change Our Testing Approach?

In this article, Chief Scientific Officer at BioAgilytix, Jim McNally, Ph.D., explores why bioanalysts should prepare for the impending wave of C&GTs entering the development…

Media Coverage

Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter…